These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 38780911)
21. [Herpes zoster and postherpetic neuralgia - prevention by vaccination?]. Wutzler P Dtsch Med Wochenschr; 2009 Apr; 134 Suppl 2():S90-4. PubMed ID: 19353479 [TBL] [Abstract][Full Text] [Related]
22. Development of adjuvanted recombinant zoster vaccine and its implications for shingles prevention. Lecrenier N; Beukelaers P; Colindres R; Curran D; De Kesel C; De Saegher JP; Didierlaurent AM; Ledent EY; Mols JF; Mrkvan T; Normand-Bayle M; Oostvogels L; Da Silva FT; Vassilev V; Vinals C; Brecx A Expert Rev Vaccines; 2018 Jul; 17(7):619-634. PubMed ID: 30028651 [TBL] [Abstract][Full Text] [Related]
23. Exploring the Link between Varicella-Zoster Virus, Autoimmune Diseases, and the Role of Recombinant Zoster Vaccine. Ishihara R; Watanabe R; Shiomi M; Katsushima M; Fukumoto K; Yamada S; Okano T; Hashimoto M Biomolecules; 2024 Jun; 14(7):. PubMed ID: 39062454 [TBL] [Abstract][Full Text] [Related]
24. Herpes zoster in outpatient departments of healthcare centers in India: a review of literature. Patki A; Vora A; Parikh R; Kolhapure S; Agrawal A; Dash R Hum Vaccin Immunother; 2021 Nov; 17(11):4155-4162. PubMed ID: 34520327 [TBL] [Abstract][Full Text] [Related]
25. Zoster Vaccine and the Risk of Postherpetic Neuralgia in Patients Who Developed Herpes Zoster Despite Having Received the Zoster Vaccine. Tseng HF; Lewin B; Hales CM; Sy LS; Harpaz R; Bialek S; Luo Y; Jacobsen SJ; Reddy K; Huang PY; Zhang J; Anand S; Bauer EM; Chang J; Tartof SY J Infect Dis; 2015 Oct; 212(8):1222-31. PubMed ID: 26038400 [TBL] [Abstract][Full Text] [Related]
26. Association of asthma and herpes zoster, the role of vaccination: A literature review. Shrestha AB; Umar TP; Mohammed YA; Aryal M; Shrestha S; Sapkota UH; Adhikari L; Shrestha S Immun Inflamm Dis; 2022 Nov; 10(11):e718. PubMed ID: 36301037 [TBL] [Abstract][Full Text] [Related]
27. Patil A; Goldust M; Wollina U Viruses; 2022 Jan; 14(2):. PubMed ID: 35215786 [TBL] [Abstract][Full Text] [Related]
28. Quantification of a cell-mediated immune response against varicella zoster virus by assessing responder CD4 Haredy AM; Takei M; Iwamoto SI; Ohno M; Kosaka M; Hirota K; Koketsu R; Okuno T; Ikuta K; Yamanishi K; Ebina H Vaccine; 2019 Aug; 37(36):5225-5232. PubMed ID: 31358406 [TBL] [Abstract][Full Text] [Related]
35. Shingrix for Herpes Zoster: A Review. Shah RA; Limmer AL; Nwannunu CE; Patel RR; Mui UN; Tyring SK Skin Therapy Lett; 2019 Jul; 24(4):5-7. PubMed ID: 31339679 [TBL] [Abstract][Full Text] [Related]
36. Looking back to move forward: a twenty-year audit of herpes zoster in Asia-Pacific. Chen LK; Arai H; Chen LY; Chou MY; Djauzi S; Dong B; Kojima T; Kwon KT; Leong HN; Leung EM; Liang CK; Liu X; Mathai D; Pan JY; Peng LN; Poblete ER; Poi PJ; Reid S; Tantawichien T; Won CW BMC Infect Dis; 2017 Mar; 17(1):213. PubMed ID: 28298208 [TBL] [Abstract][Full Text] [Related]
37. Cost-effectiveness analysis of a vaccination program for the prevention of herpes zoster and post-herpetic neuralgia in adults aged 50 and over in Germany. Préaud E; Uhart M; Böhm K; Aidelsburger P; Anger D; Bianic F; Largeron N Hum Vaccin Immunother; 2015; 11(4):884-96. PubMed ID: 25933182 [TBL] [Abstract][Full Text] [Related]